Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dreyer

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|June 1, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 12, 2024
Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic ChallengeFouad El Dana, Sofia Alexandra Garces Narvaez, Nader K El-Mallawany, et al.
Cancer|May 16, 2020
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 reportPurnima Singh, Xuexia Wang, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology GroupZoAnn E Dreyer, Patricia A Dinndorf, Bruce Camitta, et al.
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.
Nature Nanotechnology|June 24, 2020
Visualization of moiré superlatticesLeo J McGilly, Alexander Kerelsky, Nathan R Finney, et al.
Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Pediatric Blood & Cancer|November 18, 2014
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3)ZoAnn E Dreyer, Joanne M Hilden, Tamekia L Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association StudyXuexia Wang, Can-Lan Sun, Adolfo Quiñones-Lombraña, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|June 1, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 12, 2024
Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic ChallengeFouad El Dana, Sofia Alexandra Garces Narvaez, Nader K El-Mallawany, et al.
Cancer|May 16, 2020
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 reportPurnima Singh, Xuexia Wang, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology GroupZoAnn E Dreyer, Patricia A Dinndorf, Bruce Camitta, et al.
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.
Nature Nanotechnology|June 24, 2020
Visualization of moiré superlatticesLeo J McGilly, Alexander Kerelsky, Nathan R Finney, et al.
Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Pediatric Blood & Cancer|November 18, 2014
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3)ZoAnn E Dreyer, Joanne M Hilden, Tamekia L Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association StudyXuexia Wang, Can-Lan Sun, Adolfo Quiñones-Lombraña, et al.
Pageof 19